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Abstract
Background: P-113 (AKRHHGYKRKFH-NH2) is a 12-amino-acid histidine-rich peptide derived from histatin 5 that is
highly degradable in high salt concentrations and biological fluids such as serum, plasma and saliva. Nal-P-113, a
novel antimicrobial peptide whose histidine residues are replaced by the bulky amino acids β-naphthylalanine,
causes the antimicrobial peptide to retain its bactericidal activity even in physiological environments. This study
evaluated the effect of the novel antimicrobial peptide Nal-P-113 in a rat periodontitis model and the mechanisms
of action of Nal-P-113 for suppressing periodontitis.
Methods: Periodontitis was induced in mandibular first molars in rats receiving a ligature and infected with
Porphyromonas gingivalis. Animals were randomly divided into six groups: a, P. gingivalis W83 alone; b, P. gingivalis
W83 with 6.25 μg/mL of Nal-P-113; c, P. gingivalis W83 with 25 μg/mL of Nal-P-113; d, P. gingivalis W83 with 100 μg/mL
of Nal-P-113; e, P. gingivalis W83 with 400 μg/mL of Nal-P-113; and f, control without P. gingivalis W83 or Nal-P-113.
Morphometric analysis was used to evaluate alveolar bone loss. Microbiological assessment of the presence of
Porphyromonas gingivalis and total bacteria was performed using absolute quantitative real-time PCR and scanning
electron microscopy. Gingival tissue was collected for western blot and immunohistochemical assays of IL-1β and
TNF-α levels.
Results: Alveolar bone loss was inhibited by 100 μg/mL or 400 μg/mL of Nal-P-113 compared to the control
group (P < 0.05). Lower amounts of P. gingivalis and total bacteria were found in groups d and e compared with
group a (P < 0.05). A decrease in the levels of IL-1β and TNF-α was detected in group d and group e compared
to the control group (P < 0.05). The amount of P. gingivalis was positively correlated with IL-1β and TNF-α
expression in periodontal tissue (P < 0.05).
Conclusions: Nal-P-113 exhibited protective effects on Porphyromonas gingivalis-induced periodontitis in rats by
limiting the amount of bacteria and modulating IL-1β and TNF-α production. The use of Nal-P-113 in vivo might
serve as a beneficial preventive or therapeutic approach for periodontitis.
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Background
Chronic periodontitis is the most common oral disease
and the leading cause of tooth loss in adults [1]. Further-
more, it is a known risk factor for many systemic
diseases [2–4], such as cardiovascular disease, diabetes,
and rheumatoid arthritis.
Periodontitis is primarily initiated by exaggerated host
immune responses to periodontal pathogens, which lead
to the breakdown of periodontal connective tissues and
alveolar bone loss [5]. Among numerous periodontal
pathogens, the Gram-negative anaerobic bacterium
Porphyromonas gingivalis (P. gingivalis) is one of the key
pathogens in chronic periodontitis. P. gingivalis releases
copious amounts of virulence factors, including prote-
ases and lipopolysaccharides, which interact with toll-
like receptors or penetrate into periodontal tissues and
trigger immune responses, resulting in periodontal tissue
destruction. Therefore, eliminating periodontal patho-
gens, particularly P. gingivalis, is essential for blocking
the process of periodontitis [5]. Local drug therapy is an
effective supplementary means for the treatment of
periodontitis, for it can reach areas that curettage instru-
ments can’t. Local drug therapies have focused on
chlorhexidine and antibiotics such as roxithromycin,
spiramycin and metronidazole. Unfortunately, patients
have shown poor compliance due to the adverse side
effects of these drugs, such as bitter taste, pigmentation,
diarrhoea and vomiting. The emergence of drug resist-
ance and dysbacteriosis also limits their clinical applica-
tion [6, 7]. Therefore, it is urgent to develop novel drugs
with few side effects to fight periodontal pathogens. Re-
cently, antimicrobial peptides have become promising
antimicrobial agents due to their rapid bactericidal activ-
ities and low risk of producing drug-resistant bacterial
strains [8]. However, the application of antimicrobial
peptides has important drawbacks in vivo due to their
high degradation characteristics in the presence of
biological fluids [9–12]. Although they demonstrate
effective in vitro activities, many antimicrobial peptides
have failed in vivo application tests.
P-113 (AKRHHGYKRKFH-NH2) is a 12-amino-acid
histidine-rich peptide derived from saliva protein histatin
5. Considering its easy degradability, we improved its
chemical structure by replacing the histidine residues
with bulky amino acid β-naphthylalanine and synthe-
sized a novel antimicrobial peptide, Nal-P-113. This
structural alteration enables Nal-P-113 to be resistant to
high salt conditions, including PBS, saliva and bovine
calf serum [13, 14]. The antimicrobial and anti-biofilm
effects of the novel antimicrobial peptide Nal-P-113 have
been successfully confirmed in our previous in vitro
study together with its nontoxic effect on rat gingival
tissue. Nevertheless, to date, no study has focused on
the impact of Nal-P-113 in inhibiting periodontitis in an
animal model. In this study, we explored the effect of
locally administered Nal-P-113 in a rat model of peri-
odontitis by measuring alveolar bone loss, microbe
colonization and immune-inflammatory modulation.
We postulated that Nal-P-113 can prevent periodontal
tissue destruction in experimental periodontitis models
not only by controlling the amount of pathogens and total
bacteria but also by modulating immune-inflammatory
factors in gingiva, representing an auxiliary new approach
for periodontitis therapy.
Methods
Synthesis, purification, analysis and dilution of
antimicrobial peptide Nal-P-113
Nal-P-113, Ac-AKR-Nal-Nal-GYKRKF-Nal-NH2, was syn-
thesized from P-113 (AKRHHGYKRKFH-NH2) by
replacing His 4, 5 and 12 with β-naphthylalanines based
upon the 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase
synthesis protocol [13, 15]. Electrospray mass spectrometry
was used to identify the peptide, and high-performance
liquid chromatography (HPLC) was used to assess its
purity. The peptide concentration was determined with a
UV spectrophotometer at 280 nm. Nal-P-113 was dissolved
in sterile deionized water at concentrations of 6.25 μg/mL,
25 μg/mL, 100 μg/mL and 400 μg/mL.
Bacteria strains
The Gram-negative bacterium P. gingivalis strain W83
was obtained from the American Type Culture Collec-
tion (ATCC) and stored at the Department of Oral Biol-
ogy, China Medical University. P. gingivalis strain W83
was cultured at 37 °C for 18 h in an anaerobic chamber
with 85% N2, 10% H2, and 5% CO2 in brain heart infu-
sion broth (Difco, Detroit, MI) supplemented with yeast
extract (5 mg/mL), haemin (5 μg/mL) and vitamin K1
(0.2 μg/mL).
Ethical statement
The use of rats in this study complied with Animal
Research Reporting In Vivo Experiments (ARRIVE)
guidelines. The experimental protocols were approved
by the ethics committee of China Medical University.
Animals
Five-week-old, healthy, male Sprague Dawley (SD) rats
weighing approximately 200–250 g were used. Rats were
randomly assigned to one of the following groups (24
rats for each group): a, P. gingivalis W83 alone; P. gingi-
valis W83 with b, 6.25 μg/mL of Nal-P-113; c, 25 μg/mL
of Nal-P-113; d, 100 μg/mL of Nal-P-113; e, 400 μg/mL
of Nal-P-113; and f, control group without P. gingivalis
W83 or Nal-P-113.
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Induction of rat periodontitis models
All rats received azithromycin (10 mg/500 mL) for 4 days
to reduce the original oral flora before the periodontitis
model commenced in a controlled-temperature environ-
ment (22 ± 2 °C). This treatment was followed by a
7-day antibiotics-free period. At day 0, rats in all groups
(a-f ) were anesthetized with 10% chloral hydrate. A
0.2-mm wire was placed in the dentogingival area of
both mandibular first molars. Rats in the experimental
groups (a-e) received 1 × 109 CFU/mL (1.5 mL) of P.
gingivalis W83 in the oral cavity and oesophagus when
feeding twice per day (at 8:00 a.m. and 8:00 p.m.). Rats
in group f, i.e., the control group, received 1.5 mL of
BHI broth. Two hours later, Nal-P-113 (1 mL) was
dripped into the rats’ periodontal pockets for 1 min in
groups b to e. Sterile deionized water was dripped into
the periodontal pockets in groups a and f. The above pro-
cedures continued for four weeks and were accompanied
with inhalational anaesthesia with sevoflurane each time
(Hengrui Pharmaceutical Co. Ltd., Shanghai, China).
Measurement of alveolar bone loss
Four weeks later, all rats (144/144) were healthy. After
sacrifice by spinal dislocation, the rat mandibles were
separated gently from muscle and soft tissue and
exposed overnight to 8% hydrochloric acid. A stereo-
microscope (SZX12, Olympus, Japan) equipped with a
12.5× objective was used for observing the morphology
of each rat alveolar bone in every group. YC-2008 μ
micro-measurement software (Aoka, Suzhou, China)
was used for measuring the distance between the
enamelo-cemental junction and alveolar bone crest
along the axis of the teeth. For evaluating the average
alveolar bone loss, three points were measured on the
buccal and lingual parts along the axis of the teeth. The
average bone loss was calculated for each tooth.
Bacterial colonization and distribution
Unilateral subgingival plaque and bacteria from the
buccal and lingual mucosa were collected using sterile
toothpicks and stored in 1× PBS at −80 °C. P. gingivalis
W83 and total bacteria loads were assessed using abso-
lute quantitative real-time PCR. The primers used were
as follows: P. gingivalis W83: F: 5′-CATAGATATCACG
AGGAACTCCGATT-3′ and R: 5′-AAACTGTTAGCAA
CTACCGATGTGG-3′. Universal: F: 5′-AACTGGA GGA
AGGTGGGGA-3′ and R: 5′-ACGCCAACCTAGTGGAG
GA-3′. Each reaction tube contained 20 μL of real-time
PCR reaction mixture, including 10 μL of 2× SYBR®
Premix Ex Taq§, 0.4 μL of 50× ROX Reference Dye II,
0.8 μL of 10 μM primers, 0.4 μL of template DNA and
6.8 μL of ddH2O. The amplification cycle conditions were
95 °C for 30 s, 40 cycles of 5 s each at 95 °C, and 34 s at
60 °C. The absolute quantities of the target bacteria were
determined using standard curves for P. gingivalis W83
and total bacteria. Briefly, the DNA concentrations of the
target bacterial strains were serially diluted 10-fold using
sterile water to construct standard curves and determine
the exact numbers of DNA copies in the samples by calcu-
lating ct values. All experiments were performed in tripli-
cate to ensure data accuracy. The data were analysed with
ABI 7500 software version 2.0.5 (Applied Biosystems,
Foster City, CA, USA) [16].
Contralateral molars were fixed with 2.5% glutaraldehyde
(BioChemika, Fluka), washed with PBS and subsequently
dehydrated with ethanol. The processed samples were
smeared onto a copper plate followed by gold sputtering,
and images of the enamelo-cemental junction of the first
molar were acquired by scanning electron microscopy
(Inspect F50, FEI Company, USA) at 20,000× magnifica-
tion. Six views were randomly selected from each animal.
Histopathologic evaluation of periodontal tissue
All mandibular periodontal tissues and tooth samples
were divided in half: the left part was immediately
cooled to −80 °C for western blotting, and the right part
was fixed in 10% formaldehyde solution at 4 °C for one
week. The samples were washed with distilled water and
placed in 10% EDTA for decalcification for 40 days,
rinsed in PBS buffer for 12 h, dehydrated, embedded and
cut into 3–4 μm sections for immunohistochemical
examination of IL-1β and TNF-α expression in peri-
odontal tissues. Sections were obtained from the tissue
that contained tooth, junctional epithelium and gingival
tissues. Six views were selected from each sample for
mean value calculations. Integrated optical density quan-
tified using a MetaMorph Imaging Microscopic Image
Analysis System (UIC, USA) was used to assess the
expression of IL-1β and TNF-α. The results were
recorded as means ± standard deviations (SD).
Western blot detection of gingival tissue
Gingival tissue at the buccal root bifurcation was used to
examine the levels of IL-1β and TNF-α. A total of 20 mg
gingival tissue sample was lysed on ice for 30 min with
RIPA lysis buffer containing protease and phosphatase
inhibitors (Sigma, St Louis, MO, USA). Supernatant pro-
teins were obtained by centrifugation at 10,000×g at 4 °C
for 10 min. Total protein was measured with a BCA
protein assay kit (Thermo Fisher Scientific, USA). Equal
amounts (15 ng) of protein samples were separated by
10% SDS-polyacrylamide gel electrophoresis (PAGE) at
100 V for 2 h and electrotransferred to PVDF mem-
branes (Millipore, Billerica, MA, USA). The membranes
were blocked in TBST (20 mM Tris, pH 7.6, 150 mM
NaCl, 0.1% Tween 20) containing non-fat dry milk for
2 h at room temperature and incubated overnight in a
1:800 dilution of anti-IL-1β and anti-TNF-α (Kaiji
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Biological Technology Co. NJ, China) for 2 h. After the
membrane was washed three times, it was incubated
with a 1:5000 dilution of goat anti-rabbit secondary anti-
body (Kaiji Biological Technology Co. NJ, China) for 1 h
at room temperature and scanned using a fluorescence
system with an anti-GAPDH antibody as an internal refer-
ence [17]. A gel imaging analysis system (SYNGENE G:
BOX ChemiXR5, USA) and Gel-Pro32 software (Media
Cybernetic, Inc., USA) were used for densitometry. Statis-
tical analysis was conducted after calculating integral
value/internal reference integral value ratios.
Statistical analysis
All experiments were performed in triplicate for each
condition. An ANOVA was used to compare the signifi-
cance among groups (SPSS Inc., Chicago, IL, USA).
Pearson linear correlation analysis was used to calculate
the correlation between P. gingivalis, total bacteria
DNA replication and the expression of IL-1β and TNF-
α cytokines. The data are presented as the means ±




First, a rat periodontitis model was successfully estab-
lished by infecting rats with P. gingivalis W83 along with
placement of a ligature around the first molars of the
rats. Alveolar bone loss is a typical characteristic of peri-
odontitis and is usually used as a marker of periodontitis
in this model [18]. A stereomicroscope observation
showed that rat alveolar bone was severely damaged in
groups a, b and c (Fig. 1B-a, b, c). Administration of
Nal-P-113 (100 μg/mL or 400 μg/mL) inhibited the
destruction of rat alveolar bone in the mandibular first
molar during the course of establishing rat periodontitis
models, especially at the location of root bifurcation
(Fig. 1B-d, e). Based upon YC-2008 software micro-
measurement, the results showed severe connective
tissue and alveolar bone destruction characterized by
an increased distance between the enamelo-cemental
junction and alveolar bone crest in the first molars
(1326.40 ± 186.04 μm) in group a (Fig. 1A-a). Nal-P-
113 (100 μg/mL or 400 μg/mL) significantly reduced
alveolar bone loss in ligated mandibular molars in
group d and e compared to that in group a (P < 0.05).
Fig. 1 Detection of rat alveolar bone damage by stereomicroscopy and immunohistochemical staining. (a) and (b) Alveolar bone loss in each
group was measured along the long axis of the teeth using a stereomicroscope. a: P. gingivalis W83 alone; b: P. gingivalis W83 plus 6.25 μg/mL
of Nal-P-113; c: P. gingivalis W83 plus 25 μg/mL of Nal-P-113; d: P. gingivalis W83 plus 100 μg/mL of Nal-P-113; e: P. gingivalis W83 plus 400 μg/mL
of Nal-P-113; f: control group, without P. gingivalis or Nal-P-113. The data are presented as the means of 12 rats in each group (a). The images were
selected from each group at random (b)
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The average distance (along the axis of the teeth) between
the enamelo-cemental junction and the alveolar bone crest
in the first mandibular molars in group d and group e was
1094.40 ± 159.04 μm and 836.20 ± 175.03 μm, respectively
(P < 0.05, Fig. 1A-d and Fig. 1A-e).
P. gingivalis W83 and total bacteria loads
A large amount of bacteria (mainly Coccus) present as a
biofilm on the surface of teeth could be observed in group
f (Fig. 2A-f), which confirmed that the resident flora in
the rats’ oral cavity was Coccus. Three-dimensional bio-
films composed of Coccus and Bacillus brevis aggregated
on the surface of teeth after feeding P. gingivalis W83.
Administration of Nal-P-113 (100 μg/mL or 400 μg/mL)
inhibited dental plaque biofilms in the rat oral cavity,
resulting in only few Coccus or Bacillus brevis colonies
scattered on the surface of teeth (Fig. 2A-d and Fig. 2A-e).
To further quantify the amounts of bacteria colonizing
the rat oral cavity, absolute quantitative real-time
PCR was performed to detect P. gingivalis W83 and
total bacteria. The results illustrated that Nal-P-113 at
high concentrations (100 μg/mL or 400 μg/mL)
significantly reduced P. gingivalis W83 and total bacteria
loads (P < 0.05, Table 1).
Expression of IL-1β and TNF-α
Immunohistochemical staining was performed, and the
percentage of inflammatory cells, including neutrophils,
lymphocytes and monocytes, was counted in 6 randomly
selected views at 400× magnification. The results showed
that in groups a and b, the percentage of inflammatory
cells was >75%, accompanied by epithelial spike thickening,
periodontal ligament fibre degeneration and alveolar bone
damage (Fig. 3A,B-a and Fig. 3A,B-b). In group a, large
amounts of IL-1β and TNF-α were found in the periodon-
tal tissue, specifically, the integrated optical density of
IL-1β and TNF-α in periodontal tissue was 54.26 ± 2.94
and 27.11 ± 1.60, respectively. Compared to group a, rats
in group b and group c demonstrated a slight reduction of
IL-1β and TNF-α levels in periodontal tissue (Fig. 3A,B-b
and Fig. 3A,B-c), but the differences were not statistically
significant (P > 0.05, Table 2). With increasing concentra-
tions of Nal-P-113, IL-1β and TNF-α levels in periodontal
tissue declined dramatically in group d and group e
(P < 0.05, Table 2). Additionally, fewer inflammatory cells
(< 50%) could be found around the alveolar bone, and the
gingival epithelium attached itself closely to the alveolar
bone with little periodontal ligament fibre breakage
(Fig. 3A,B-d and Fig. 3A,B-e).
Western blot data were consistent with the finding
that Nal-P-113 reduced IL-1β and TNF-α expression in
gingival tissue in a concentration-dependent manner. In
group a, the adjusted values for IL-1β/GAPDH and
TNF-α/GAPDH were 0.71 and 0.75, respectively. Four
doses of Nal-P-113 all reduced IL-1β and TNF-α levels
in gingival tissue compared to those in group a, even
though the expression of TNF-α was slightly increased
in group c compared with group b (Fig. 3C).
Correlation between P. gingivalis DNA replication and
cytokine expression
A Pearson linear correlation analysis was used to evalu-
ate the correlation between bacterial DNA (P. gingivalis
and total bacteria) and the expression of IL-1β and
TNF-α cytokines. The results showed that both IL-1β
and TNF-α expression in periodontal tissue were posi-
tively correlated with the copies of P. gingivalis DNA
(Fig. 4A. IL-1β: R = 0.947, P = 0.004; TNF-α: R = 0.960,
Fig. 2 Bacteria on enamelo-cemental junction of rats’ teeth detected by scanning electron microscopy. a: P. gingivalis W83 alone; b: P. gingivalis
W83 plus 6.25 μg/mL of Nal-P-113; c: P. gingivalis W83 plus 25 μg/mL of Nal-P-113; d: P. gingivalis W83 plus 100 μg/mL of Nal-P-113; e: P. gingivalis
W83 plus 400 μg/mL of Nal-P-113; f: control group, without P. gingivalis W83 or Nal-P-113. SEM magnification, 20,000×. Red arrows indicate P. gingivalis
W83; white arrows indicate Coccus, a genus of resident bacteria in the rat oral cavity; yellow arrows indicate the rat tooth surface
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P = 0.002). Nevertheless, the total bacterial DNA did not
correlate with IL-1β or TNF-α expression (Fig. 4B. IL-1β:
R = 0.622, P = 0.187; TNF-α: R = 0.573, P = 0.235).
Discussions
Periodontitis is a complex disorder dependent on many
factors, but inflammatory cell accumulation induced by
microorganisms in periodontal tissues is considered the
primary causative factor. P. gingivalis, a member of the
red complex, is considered one of the most important
pathogenic factors of periodontitis, which produces
several virulence factors, including lipopolysaccharide,
capsules, fimbriae and a group of proteolytic enzymes
that damage periodontal tissue [19–21]. In addition, P.
gingivalis can trigger changes to the amount and compos-
ition of the oral commensal microbiota, leading to inflam-
matory periodontal bone loss [22]. In this condition, the
removal of periodontal pathogens, such as P. gingivalis, is
Table 1 DNA copy numbers of P. gingivalis W83 and total bacteria loads
group a group b group c group d group e group f
P. gingivalis W83 (1.74 ± 0.12)E + 17 (1.71 ± 0.10)E + 17 (1.69 ± 0.11)E + 17 (1.06 ± 0.034)E+17a (6.21 ± 0.24)E+16a -
Total bacteria (2.19 ± 0.29)E + 20 (2.03 ± 0.10)E + 20 (1.98 ± 0.05) E + 20 (1.01 ± 0.051)E+20a (6.97 ± 0.61)E+19a (1.89 ± 0.071)E + 20
aP < 0.05, compared with group a
Fig. 3 Expression of IL-1β and TNF-α in periodontal tissue. a IL-1β expression in the periodontal tissue of rats detected by immunohistochemistry.
Brown staining indicates positive immunoreactivity. b TNF-α expression in the periodontal tissue of rats detected by immunohistochemistry. Brown
staining indicates positive immunoreactivity. c Levels of IL-1β and TNF-α detected by western blot analysis. The mean values of IL-1β and TNF-α were
measured by densitometry using Gel-Pro32 software. a: P. gingivalis W83 alone; b: P. gingivalis W83 plus 6.25 μg/mL of Nal-P-113; c: P. gingivalis W83
plus 25 μg/mL of Nal-P-113; d: P. gingivalis W83 plus 100 μg/mL of Nal-P-113; e: P. gingivalis W83 plus 400 μg/mL of Nal-P-113; f: control group, without
P. gingivalis or Nal-P-113. The data are presented as the means of 12 rats in each group. Magnification, 100×
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an effective method to block chronic periodontitis.
Although periodontal pathogens are required for
disease initiation, the extent and severity of periodontal
damage depend on the nature of the host response to
bacterial challenge. The development of a novel thera-
peutic strategy combining both the antibacterial activity
and the host-modulatory effect of a new drug could
increase the likelihood of successfully managing peri-
odontitis [23]. Some studies have shown that antimicrobial
peptides, in addition to exhibiting a direct antimicrobial
activity, possess a wide range of immunomodulatory
properties [24]. In animal models, researchers have
verified that antimicrobial peptides are effective in
oral Candidiasis infection, lung infection and sinusitis
[25–27], but few studies have focused on periodontitis
therapy in vivo. The present study evaluated, for the first
time, the anti-inflammatory and antimicrobial impact of a
novel antimicrobial peptide Nal-P-113 in preventing the
progression of periodontitis in a concentration-dependent
manner.
Table 2 Integrated optical densities of the immunohistochemical staining for IL-1β and TNF-α
Controls P. gingivalis Nal-P-113 (n = 12)
(n = 12) (n = 12) 6.25 μg/mL 25 μg/mL 100 μg/mL 400 μg/mL
IL-1β 5.32 ± 0.93 54.26 ± 2.94 49.32 ± 9.81 40.50 ± 5.61 19.78 ± 3.40a 12.40 ± 2.51a
TNF-α 4.63 ± 0.57 27.11 ± 1.60 24.63 ± 5.17 20.94 ± 3.77 12.62 ± 2.67a 9.09 ± 2.07a
aP < 0.05, compared with the P. gingivalis group
Fig. 4 a Linear correlation curve of the P. gingivalis’ DNA copy number and cytokines in periodontal tissue (IL-1β and TNF-α). The integrated optical
densities of IL-1β and TNF-α were calculated on the basis of immunohistochemical staining. The levels of IL-1β and TNF-α in rat periodontal tissue
showed a significant positive linear correlation with DNA copy number of P. gingivalis (P < 0.05). b Linear correlation curve of the total bacteria DNA
copy number and cytokines in periodontal tissue (IL-1β and TNF-α). The integrated optical densities of IL-1β and TNF-α were calculated on the basis of
immunohistochemical staining. There was not a significant positive linear correlation between IL-1β or TNF-α expression levels in rat periodontal tissue
and DNA copy number of total bacteria (P > 0.05)
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In the current investigation, morphometric analysis
demonstrated that therapy with Nal-P-113 promoted a
significant decrease in bone loss compared to high
periodontal breakdown in the non-treated group. The
enamelo-cemental junction area served as an observa-
tion locus to explore the bacterial distribution on the rat
tooth surface. Scanning electron microscopy showed
that bacteria adhering to the surfaces of teeth in a scat-
tered distribution were impacted by high concentrations
of Nal-P-113. Consistent with the morphological images,
quantitative real-time PCR confirmed the results that
treatment with 100 μg/mL or 400 μg/mL of Nal-P-113 re-
duced the amount of P. gingivalis and total bacteria loads
compared with those in the control group (P < 0.05). A
previous study showed that Nal-P-113 inhibited bacterial
growth even caused bacterial death by permeabilizing
and/or forming pores within cytoplasmic membranes in a
concentration-dependent manner in vitro [14]. The
present study demonstrated the ability of the novel anti-
microbial peptide Nal-P-113 to inhibit biofilm formation,
local inflammatory response and alveolar bone loss in an
experimental rat periodontitis model.
Bacteria are essential for the development of peri-
odontitis but not sufficient to cause disease alone. For
periodontitis to develop, a susceptible host is required
[28, 29]. Page et al. in 1999 reported that periodontal
disease was characterized by high concentrations of
matrix metalloproteinases (MMPs), cytokines, and
prostaglandins in the periodontal tissue.23 Certain
cytokines, including IL-1β and TNF-α, play a critical
role in the pathogenesis of periodontitis. IL-1β and
TNF-α are both pro-inflammatory cytokines involved in
the induction of several other inflammatory mediators in
periodontal inflammation, such as IL-6, chemokines,
MMPs and prostaglandin E2 [30]. Furthermore, IL-1β and
TNF-α can induce secondary mediators, resulting in
inflammatory response expansion, connective tissue
destruction and osteoclastic bone resorption [31]. To
explore the host involvement in the disease process,
immunohistochemical techniques and western blotting
were used to detect IL-1β and TNF-α expression in
the periodontal tissue of rats. The results showed that
Nal-P-113 reduced IL-1β and TNF-α levels in peri-
odontal tissue in a concentration-dependent manner.
Many scholars have also confirmed that other anti-
microbial peptides were capable of modulating innate
immunity [32–34]. For example, Pingel et al. reported
that human beta-defensin (hBD)-3 significantly decreased
the secretion of IL-6, IL-10, GM-CSF and TNF-α by
human myeloid dendritic cells stimulated with recombin-
ant Porphyromonas gingivalis hemagglutinin B [34]. LL-37
induced production of pro-inflammatory cytokines IL-4,
IL-5 and IL-1β from human mast cell [35] or by activation
of P2X7 receptor from monocytes [36]. Some immune
cells, such as macrophages or mast cells, can express G
protein-coupled receptors and have a role in both innate
immune responses and antimicrobial activation [24]. But
in our study, we didn’t find Nal-P-113 alone change IL-1β
or TNF-α levels in macrophages (Additional file 1: Figure
S1). Other immune cells, such as mast cells, monocytes
and neutrophils interact with Nal-P-113 should be investi-
gated in the future studies.
It is worth noting that the TNF-α level detected by
western blotting was slightly increased when 25 μg/mL
of antimicrobial peptide Nal-P-113 was used. One po-
tential explanation might be that antimicrobial peptides
themselves can induce a slight up-regulation of TNF-α
expression [37]. Our results showed that 25 μg/mL or
400 μg/mL Nal-P-113 increased TNF-α expression
levels in human periodontal ligament stem cells, but
not in immortalized human gingival epithelial cells or
macrophages (Additional file 1: Figure S1). The specific
mechanism is not clear, maybe it decreased the MyD88
and AKT levels to affect the NF-κB signaling pathway
and modulated TNF-α response [38]. To some extent,
the host-defence mechanisms are sustained by an
large network of anti- and pro-inflammatory media-
tors that may exert antagonistic and/or synergistic
biological activities, further studies are required to
better understand the role of Nal-P-113 in the modu-
lation of immune-inflammatory responses.
Based on the correlation analysis, IL-1β and TNF-α
levels in gingival tissue were positively correlated with
P. gingivalis but not with the total amount of bac-
teria. Therefore, in the process of host-microbial
interactions, P. gingivalis played a more important
role in promoting IL-1β and TNF-α expression than
other oral bacteria. We surmise that the antimicrobial
peptide Nal-P-113 might interrupt pre-inflammatory
cytokine expression by reducing P. gingivalis loads in
the rat oral cavity.
Conclusions
Overall, the present investigation demonstrates that a
novel antimicrobial peptide, Nal-P-113, not only over-
comes the degradation susceptibility of antimicrobial
peptides in vivo but also exerts potent preventive
effects on rat periodontitis. This peptide inhibits P.
gingivalis-induced local inflammatory response and
alveolar bone loss by reducing the amount of bacteria
directly and down-regulating pro-inflammatory mole-
cules such as IL-1β and TNF-α. Though further studies
are needed to determine the exact mechanism of host-
microbial interactions in periodontitis treated with anti-
microbial peptides, these agents have the potential to
be used as a new preventive or therapeutic strategy for
chronic periodontitis in the clinic.
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Additional file
Additional file 1: Figure S1. (A) IL-1β levels of immortalized human
gingival epithelial cells, human periodontal ligament stem cells and
macrophages after co-cultured with Nal-P-113 for 2 h. Nal-P-113 (25 μg/mL
or 400 μg/mL) did not change the levels of IL-1β expression in immortalized
human gingival epithelial cells, human periodontal ligament stem cells or
macrophages detected by enzyme-linked immunosorbent assay (P > 0.05).
(B) TNF-α levels of immortalized human gingival epithelial cells, human
periodontal ligament stem cells and macrophages after co-cultured with
Nal-P-113 for 2 h. Nal-P-113 (25 μg/mL or 400 μg/mL) increased TNF-α levels
in periodontal ligament cells (P < 0.05), but not in gingival epithelial cells or
macrophages (P > 0.05). (JPEG 453 kb)
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CFU: Colony forming units; HPLC: High-performance liquid chromatography;
IL-1β: interleukin-1 beta; MMPs: Matrix metalloproteinases; qPCR: Quantitative
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